ID: ALA3828292

Max Phase: Preclinical

Molecular Formula: C12H7N5O

Molecular Weight: 237.22

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  c1ccc2oc(-c3ccnc4nnnn34)cc2c1

Standard InChI:  InChI=1S/C12H7N5O/c1-2-4-10-8(3-1)7-11(18-10)9-5-6-13-12-14-15-16-17(9)12/h1-7H

Standard InChI Key:  XTZALLKANSEPMC-UHFFFAOYSA-N

Associated Targets(Human)

Pancreatic alpha-amylase 74 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Alpha-glucosidase MAL12 70 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 237.22Molecular Weight (Monoisotopic): 237.0651AlogP: 1.93#Rotatable Bonds: 1
Polar Surface Area: 69.11Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 1.50CX LogD: 1.50
Aromatic Rings: 4Heavy Atoms: 18QED Weighted: 0.51Np Likeness Score: -1.47

References

1. Suresh L, Onkara P, Kumar PS, Pydisetty Y, Chandramouli GV..  (2016)  Ionic liquid-promoted multicomponent synthesis of fused tetrazolo[1,5-a]pyrimidines as α-glucosidase inhibitors.,  26  (16): [PMID:27406797] [10.1016/j.bmcl.2016.06.086]

Source